ANTIBIOTICS

 

At Qurewell HealthScience Pvt. Ltd., we offer a comprehensive range of antibiotics designed to effectively treat various bacterial infections. Our commitment to quality and efficacy ensures that healthcare professionals can rely on our products to help their patients achieve optimal health. Our Antibiotics portfolio is crafted with precision, utilizing advanced formulations that address diverse medical needs.

Our Antibiotics Product Range:

Cefzum

Cefzum is a powerful broad-spectrum cephalosporin antibiotic, designed to effectively combat a wide range of bacterial infections. It works by inhibiting bacterial cell wall synthesis, which leads to the destruction of the bacteria. 

Cefzum is particularly useful in treating respiratory tract infections, urinary tract infections, skin infections, and other conditions caused by susceptible bacteria. Its broad-spectrum activity makes it a reliable choice for treating infections caused by both Gram-positive and Gram-negative organisms. Cefzum provides strong, dependable antibacterial action, ensuring rapid relief from infections and promoting faster recovery.

Cefzum Cef

Cefzum Cef is a powerful broad-spectrum injectable cephalosporin antibiotic, designed to treat a wide range of bacterial infections effectively. Its broad-spectrum action targets both Gram-positive and Gram-negative bacteria, making it a versatile solution for severe infections such as respiratory tract infections, skin infections, urinary tract infections, and septicemia. 

As an injectable formulation, Cefzum Cef ensures rapid absorption and immediate action, making it particularly useful in hospital settings or for serious infections where quick intervention is needed. This cephalosporin provides potent antibacterial efficacy, helping patients recover faster from bacterial infections.

Qurepenem

Qurepenem is an injectable antibiotic specifically formulated for the treatment of severe, life-threatening infections. Known for its high safety and efficacy rates, Qurepenem is a broad-spectrum carbapenem antibiotic that works by inhibiting bacterial cell wall synthesis, leading to the elimination of both Gram-positive and Gram-negative bacteria, as well as certain resistant strains. 

It is particularly effective in treating serious infections such as pneumonia, sepsis, complicated intra-abdominal infections, and other critical bacterial conditions. Qurepenem is often used in hospital settings where rapid and reliable treatment is crucial, providing patients with a highly effective solution for combating life-threatening infections.

Qureclav

Qureclav is a potent broad-spectrum antibiotic formulated to combat a wide range of bacterial infections, including those caused by beta-lactamase-producing pathogens. This powerful combination of an antibiotic with a beta-lactamase inhibitor ensures enhanced efficacy against resistant bacteria that produce beta-lactamase enzymes, which normally render some antibiotics ineffective. 

Qureclav is particularly effective in treating respiratory tract infections, skin and soft tissue infections, urinary tract infections, and other bacterial conditions. Its broad-spectrum activity and ability to target resistant bacteria make Qureclav a reliable choice for treating complex and challenging infections, ensuring a faster and more effective recovery.

Cefzum-CV

Cefzum-CV is a powerful broad-spectrum cephalosporin antibiotic formulated to effectively target and treat infections caused by extended-spectrum beta-lactamase (ESBL) producing organisms. These resistant bacteria are difficult to treat with standard antibiotics, but Cefzum-CV, combined with a beta-lactamase inhibitor, neutralizes the bacteria’s defense mechanisms, ensuring potent antibacterial action. 

It is particularly useful in treating serious infections such as complicated urinary tract infections, respiratory infections, and abdominal infections. With its extended coverage against resistant pathogens, Cefzum-CV is a highly reliable option for managing tough bacterial infections and promoting faster recovery.

Tazomaze-4.5

Tazomaze-4.5 is a potent injectable antibiotic combination designed for the empirical treatment of severe infections. It combines piperacillin, a broad-spectrum penicillin antibiotic, with tazobactam, a beta-lactamase inhibitor that enhances its effectiveness against beta-lactamase-producing bacteria. 

This powerful combination targets a wide range of Gram-positive, Gram-negative, and anaerobic bacteria, making it particularly effective for treating life-threatening infections such as sepsis, pneumonia, intra-abdominal infections, and complicated skin infections. 

Tazomaze-4.5 is especially valuable in hospital settings where rapid and broad coverage is required before the specific bacterial pathogen is identified, ensuring a strong and effective first-line defense against severe infections.

Lidwell

Lidwell is a highly effective antibiotic specifically designed for treating Gram-positive bacterial infections. It is particularly useful in targeting common Gram-positive pathogens, including Staphylococcus and Streptococcus species, which are often responsible for skin infections, respiratory infections, and certain types of sepsis. 

Lidwell’s mechanism of action focuses on inhibiting bacterial protein synthesis, leading to the elimination of the infection. Its targeted efficacy against Gram-positive organisms makes it an antibiotic of choice in treating conditions like cellulitis, pneumonia, and endocarditis, ensuring reliable outcomes in managing these infections.

Ziftor-O

Ziftor-O is a combination antibiotic designed to provide assured results in both children and adults. Its formulation combines two powerful antibiotics that work together to treat a wide range of bacterial infections. 

Ziftor-O is highly effective against various Gram-positive and Gram-negative bacteria, making it suitable for treating respiratory tract infections, ear infections, urinary tract infections, and gastrointestinal infections. 

This combination offers enhanced bacterial eradication, ensuring faster recovery and minimizing the risk of resistance. Ziftor-O is a trusted choice for treating infections in patients of all ages, providing reliable and efficient results.

Cezfum CS

Cezfum CS is a broad-spectrum antibiotic combination that provides enhanced coverage against a wide range of bacterial infections, including those caused by beta-lactamase-producing bacteria. The combination of a cephalosporin antibiotic with a beta-lactamase inhibitor ensures that Cezfum CS effectively neutralizes resistant bacteria that produce beta-lactamase enzymes, which typically inactivate standard antibiotics. 

This makes it particularly useful in treating respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other complicated bacterial infections. Cezfum CS offers a robust and reliable solution for managing challenging infections, ensuring rapid recovery and preventing the spread of resistant bacterial strains.

Qurepod

Qurepod is a 3rd generation oral cephalosporin combined with a beta-lactamase inhibitor, offering enhanced efficacy against a wide range of bacterial infections. This combination works by inhibiting the action of beta-lactamase enzymes produced by resistant bacteria, allowing the cephalosporin to effectively destroy the bacteria. 

Qurepod is particularly effective in treating respiratory tract infections, urinary tract infections, skin infections, and other bacterial conditions that may involve resistant pathogens. Its broad-spectrum activity, combined with the protection against beta-lactamase-producing bacteria, makes Qurepod a reliable and convenient option for treating moderate to severe infections in an outpatient setting.

Qurepod 50/100

Qurepod-50/100 is a pediatric formulation of a 3rd generation oral cephalosporin combined with a beta-lactamase inhibitor, specifically designed to address bacterial infections in children. This combination provides enhanced protection against a wide range of pathogens, including those that produce beta-lactamase enzymes, which can render standard antibiotics ineffective. 

Qurepod-50/100 is effective in treating various infections, such as respiratory tract infections, urinary tract infections, and skin infections, ensuring that pediatric patients receive optimal care. Its palatable formulation makes it easier for children to take, while the broad-spectrum activity ensures a reliable and effective treatment option for managing infections in this vulnerable population.

Qureclav

Qureclav is a beta-lactam antibiotic known for its wide spectrum of activity against various bacterial infections, including those caused by beta-lactamase-producing bacteria. This powerful formulation combines an antibiotic with a beta-lactamase inhibitor, effectively overcoming resistance mechanisms and ensuring potent antibacterial action. 

In addition to its efficacy against a broad range of pathogens, Qureclav is also designed to preserve gut flora, promoting a healthy balance of beneficial bacteria during antibiotic treatment. This dual action not only helps combat infections but also minimizes the risk of antibiotic-associated gastrointestinal disturbances, making Qureclav an ideal choice for comprehensive infection management while supporting overall gut health.

Why Choose Qurewell Health Science Pvt. Ltd. For Antibiotics Solutions?

At Qurewell HealthScience Pvt. Ltd., our Antibiotics range is developed to meet the highest standards of safety and efficacy. 

We prioritize quality, ensuring that our products are:

  • Clinically Tested: Each antibiotic undergoes rigorous clinical trials to ensure its safety and effectiveness in treating infections.
  • Broad-Spectrum: Our range provides solutions for various types of bacterial infections, allowing healthcare providers to choose the right treatment for their patients.
  • Recommended by Professionals: Our antibiotics are trusted and prescribed by healthcare professionals worldwide, ensuring patient safety and satisfaction.

Our commitment to developing effective antibiotic solutions helps patients recover from infections, contributing to better health outcomes.